Comparison of the uptake mechanisms of zwitterionic and negatively charged liposomes by HeLa cells

Ferrari, 2005, Cancer nanotechnology: opportunities and challenges, Nat Rev Cancer, 5, 161, 10.1038/nrc1566 Lammers, 2011, Theranostic nanomedicine, Acc Chem Res, 44, 1029, 10.1021/ar200019c Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat Rev Cancer, 17, 20, 10.1038/nrc.2016.108 Wilhelm, 2016, Analysis of nanoparticle delivery to tumours, Nat Rev Mater, 1, 16014, 10.1038/natrevmats.2016.14 Pelaz, 2017, Diverse applications of nanomedicine, ACS Nano, 11, 2313, 10.1021/acsnano.6b06040 Venditto, 2013, Cancer nanomedicines: so many papers and so few drugs!, Adv Drug Deliv Rev, 65, 80, 10.1016/j.addr.2012.09.038 Monopoli, 2012, Biomolecular coronas provide the biological identity of nanosized materials, Nat Nanotechnol, 7, 779, 10.1038/nnano.2012.207 Nel, 2009, Understanding biophysicochemical interactions at the nano–bio interface, Nat Mater, 8, 543, 10.1038/nmat2442 Owens, 2006, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int J Pharm, 307, 93, 10.1016/j.ijpharm.2005.10.010 Moghimi, 2003, Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties, Prog Lipid Res, 42, 463, 10.1016/S0163-7827(03)00033-X Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat Biotechnol, 33, 941, 10.1038/nbt.3330 Aggarwal, 2009, Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy, Adv Drug Deliv Rev, 61, 428, 10.1016/j.addr.2009.03.009 Salvati, 2013, Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface, Nat Nanotechnol, 8, 137, 10.1038/nnano.2012.237 Mirshafiee, 2013, Protein corona significantly reduces active targeting yield, Chem Commun, 49, 2557, 10.1039/c3cc37307j Lara, 2017, Identification of receptor binding to the biomolecular Corona of nanoparticles, ACS Nano, 11, 1884, 10.1021/acsnano.6b07933 Caracciolo, 2013, Selective targeting capability acquired with a protein Corona adsorbed on the surface of 1,2-Dioleoyl-3-trimethylammonium propane/DNA nanoparticles, ACS Appl Mater Interfaces, 5, 13171, 10.1021/am404171h Schöttler, 2016, Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers, Nat Nanotechnol, 11, 372, 10.1038/nnano.2015.330 Tenzer, 2011, Nanoparticle size is a critical physicochemical determinant of the human blood plasma Corona: a comprehensive quantitative proteomic analysis, ACS Nano, 5, 7155, 10.1021/nn201950e Walkey, 2012, Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment, Chem Soc Rev, 41, 2780, 10.1039/C1CS15233E Lundqvist, 2008, a. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts, Proc Natl Acad Sci, 105, 14265, 10.1073/pnas.0805135105 Otsuka, 2003, PEGylated nanoparticles for biological and pharmaceutical applications, Adv Drug Deliv Rev, 55, 403, 10.1016/S0169-409X(02)00226-0 Harris, 2003, Effect of pegylation on pharmaceuticals, Nat Rev Drug Discov, 2, 214, 10.1038/nrd1033 Dai Q, Walkey C, Chan WCW. Polyethylene Glycol Backfilling Mitigates the Negative Impact of the Protein Corona on Nanoparticle Cell Targeting. Angew Chemie Int Ed. 2014 Apr 2;53(20):n/a-n/a. Rodriguez, 2013, Minimal “self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles, Science, 339, 971, 10.1126/science.1229568 Parodi, 2013, Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions, Nat Nanotechnol, 8, 61, 10.1038/nnano.2012.212 Hu, 2011, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform, Proc Natl Acad Sci, 108, 10980, 10.1073/pnas.1106634108 Caracciolo, 2015, Liposome–protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines, Nanomedicine Nanotechnology, Biol Med, 11, 543, 10.1016/j.nano.2014.11.003 García, 2014, Zwitterionic-coated “stealth” nanoparticles for biomedical applications: recent advances in countering biomolecular Corona formation and uptake by the mononuclear phagocyte system, Small, 10, 2516, 10.1002/smll.201303540 Safavi-Sohi, 2016, Bypassing protein Corona issue on active targeting: Zwitterionic coatings dictate specific interactions of targeting moieties and cell receptors, ACS Appl Mater Interfaces, 8, 22808, 10.1021/acsami.6b05099 Yang, 2020, Tuning liposome composition to modulate the corona forming in human serum and uptake by cells, Acta Biomater, 106, 314, 10.1016/j.actbio.2020.02.018 Weissig, 2014, Nanopharmaceuticals (part 1): products on the market, Int J Nanomedicine, 9, 4357, 10.2147/IJN.S46900 Barenholz, 2001, Liposome application: problems and prospects, Curr Opin Colloid Interface Sci, 6, 66, 10.1016/S1359-0294(00)00090-X Gao, 1991, A novel cationic liposome reagent for efficient transfection of mammalian cells, Biochem Biophys Res Commun, 179, 280, 10.1016/0006-291X(91)91366-K Miller, 1998, Cationic liposome systems in gene therapy, IDrugs, 1, 574 Allen, 2013, Liposomal drug delivery systems: from concept to clinical applications, Adv Drug Deliv Rev, 65, 36, 10.1016/j.addr.2012.09.037 Pichon, 2010, Chemical vectors for gene delivery: uptake and intracellular trafficking, Curr Opin Biotechnol, 21, 640, 10.1016/j.copbio.2010.07.003 Li, 2016, Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes, Biochim Biophys Acta - Biomembr, 1858, 1801, 10.1016/j.bbamem.2016.04.014 Un, 2012, Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes, Biomaterials, 33, 8131, 10.1016/j.biomaterials.2012.07.030 Sahay, 2010, The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents, Biomaterials, 31, 923, 10.1016/j.biomaterials.2009.09.101 Kang, 2017, The effect of surface charges on the cellular uptake of liposomes investigated by live cell imaging, Pharm Res, 34, 704, 10.1007/s11095-017-2097-3 Dausend, 2008, Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells, Macromol Biosci, 8, 1135, 10.1002/mabi.200800123 Vercauteren, 2010, The use of inhibitors to study Endocytic pathways of gene carriers: optimization and pitfalls, Mol Ther, 18, 561, 10.1038/mt.2009.281 Al Soraj, 2012, siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-tat, J Control Release, 161, 132, 10.1016/j.jconrel.2012.03.015 Rejman, 2004, Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis, Biochem J, 377, 159, 10.1042/bj20031253 Francia, 2019, Corona composition can affect the mechanisms cells use to internalize nanoparticles, ACS Nano, 13, 11107, 10.1021/acsnano.9b03824 Francia, 2019, Limits and challenges in using transport inhibitors to characterize how nano-sized drug carriers enter cells, Nanomedicine, 14, 1533, 10.2217/nnm-2018-0446 Villanueva, 2009, The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells, Nanotechnology, 20, 115103, 10.1088/0957-4484/20/11/115103 Deng, 2011, Nanoparticle-induced unfolding of fibrinogen promotes mac-1 receptor activation and inflammation, Nat Nanotechnol, 6, 39, 10.1038/nnano.2010.250 Bajoria, 1997, Endocytotic uptake of small unilamellar liposomes by human trophoblast cells in culture, Hum Reprod, 12, 1343, 10.1093/humrep/12.6.1343 Lee, 1992, Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density, Biochim Biophys Acta - Biomembr., 1103, 185, 10.1016/0005-2736(92)90086-2 Iversen, 2011, Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies, Nano Today, 6, 176, 10.1016/j.nantod.2011.02.003 Wang, 1993, Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation, J Cell Biol, 123, 1107, 10.1083/jcb.123.5.1107 Flanagan, 1980, Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin, J Biol Chem, 255, 835, 10.1016/S0021-9258(19)86105-7 Hoebeke, 1976, Interaction of oncodazole (R 17934), a new anti-tumoral drug, with rat brain tubulin, Biochem Biophys Res Commun, 69, 319, 10.1016/0006-291X(76)90524-6 Koivusalo, 2010, Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling, J Cell Biol, 188, 547, 10.1083/jcb.200908086 Sandvig, 2011, Clathrin-independent endocytosis: mechanisms and function, Curr Opin Cell Biol, 23, 413, 10.1016/j.ceb.2011.03.007 Salvioni, 2019, Thirty years of Cancer Nanomedicine: success, frustration, and Hope, Cancers (Basel), 11, 1855, 10.3390/cancers11121855 Chang, 2011, Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy, Int J Nanomedicine, 7, 49 Parent, 2014, An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium, Biochem Biophys Res Commun, 450, 7, 10.1016/j.bbrc.2014.05.038